Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Changes in Blood Pressure and Urine Albumin-Creatinine Ratio in a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema.

Glassman AR, Liu D, Jampol LM, Sun JK; Diabetic Retinopathy Clinical Research Network.

Invest Ophthalmol Vis Sci. 2018 Mar 1;59(3):1199-1205. doi: 10.1167/iovs.17-22853.

2.

Diabetic retinopathy: current understanding, mechanisms, and treatment strategies.

Duh EJ, Sun JK, Stitt AW.

JCI Insight. 2017 Jul 20;2(14). pii: 93751. doi: 10.1172/jci.insight.93751. [Epub ahead of print] Review.

3.

Diabetic Retinopathy: A Position Statement by the American Diabetes Association.

Solomon SD, Chew E, Duh EJ, Sobrin L, Sun JK, VanderBeek BL, Wykoff CC, Gardner TW.

Diabetes Care. 2017 Mar;40(3):412-418. doi: 10.2337/dc16-2641. Review. No abstract available. Erratum in: Diabetes Care. 2017 Jul 13;:. Diabetes Care. 2017 Jun;40(6):809.

4.

Computational fluid dynamics assisted characterization of parafoveal hemodynamics in normal and diabetic eyes using adaptive optics scanning laser ophthalmoscopy.

Lu Y, Bernabeu MO, Lammer J, Cai CC, Jones ML, Franco CA, Aiello LP, Sun JK.

Biomed Opt Express. 2016 Nov 4;7(12):4958-4973. doi: 10.1364/BOE.7.004958. eCollection 2016 Dec 1.

5.

Cone Photoreceptor Irregularity on Adaptive Optics Scanning Laser Ophthalmoscopy Correlates With Severity of Diabetic Retinopathy and Macular Edema.

Lammer J, Prager SG, Cheney MC, Ahmed A, Radwan SH, Burns SA, Silva PS, Sun JK.

Invest Ophthalmol Vis Sci. 2016 Dec 1;57(15):6624-6632. doi: 10.1167/iovs.16-19537.

6.

Out of Sight: Culture-Negative Endocarditis and Endophthalmitis.

Dugdale C, Brown S, Davila C, Wolkow N, Fishbein G, Sun J, Barkoudah E, Rawizza H.

Am J Med. 2017 Feb;130(2):e51-e53. doi: 10.1016/j.amjmed.2016.08.029. Epub 2016 Sep 13. No abstract available.

7.

Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema.

Wells JA, Glassman AR, Jampol LM, Aiello LP, Antoszyk AN, Baker CW, Bressler NM, Browning DJ, Connor CG, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW; Diabetic Retinopathy Clinical Research Network.

JAMA Ophthalmol. 2016 Feb;134(2):127-34. doi: 10.1001/jamaophthalmol.2015.4599. Erratum in: JAMA Ophthalmol. 2016 Apr;134(4):469.

8.

Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.

Writing Committee for the Diabetic Retinopathy Clinical Research Network, Gross JG, Glassman AR, Jampol LM, Inusah S, Aiello LP, Antoszyk AN, Baker CW, Berger BB, Bressler NM, Browning D, Elman MJ, Ferris FL 3rd, Friedman SM, Marcus DM, Melia M, Stockdale CR, Sun JK, Beck RW.

JAMA. 2015 Nov 24;314(20):2137-46. doi: 10.1001/jama.2015.15217. Erratum in: JAMA. 2016 Mar 1;315(9):944.

9.

Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial.

Aiello LP, Ayala AR, Antoszyk AN, Arnold-Bush B, Baker C, Bressler NM, Elman MJ, Glassman AR, Jampol LM, Melia M, Nielsen J, Wolpert HA; Diabetic Retinopathy Clinical Research Network.

JAMA Ophthalmol. 2015 Aug;133(8):888-96. doi: 10.1001/jamaophthalmol.2015.1312.

10.

Cardiovascular disease protection in long-duration type 1 diabetes and sex differences.

He ZH, D'Eon SA, Tinsley LJ, Fitzgerald S, Hastings SM, Khamaisi M, Sun JK, Turek SJ, Schaefer EJ, King GL, Keenan HA.

Diabetes Care. 2015 May;38(5):e73-4. doi: 10.2337/dc15-0017. No abstract available.

11.

Reproducibility of Optovue RTVue Optical Coherence Tomography Retinal Thickness Measurements and Conversion to Equivalent Zeiss Stratus Metrics in Diabetic Macular Edema.

Bressler SB, Edwards AR, Andreoli CM, Edwards PA, Glassman AR, Jaffe GJ, Melia M, Sun JK; for the Diabetic Retinopathy Clinical Research Network/Writing Committee.

Transl Vis Sci Technol. 2015 Jan 22;4(1):5. eCollection 2015 Jan.

12.

Neural Retinal Disorganization as a Robust Marker of Visual Acuity in Current and Resolved Diabetic Macular Edema.

Sun JK, Radwan SH, Soliman AZ, Lammer J, Lin MM, Prager SG, Silva PS, Aiello LB, Aiello LP.

Diabetes. 2015 Jul;64(7):2560-70. doi: 10.2337/db14-0782. Epub 2015 Jan 29.

13.

Feasibility and efficacy of a mass switch from ranibizumab (Lucentis) to bevacizumab (Avastin) for treatment of neovascular age-related macular degeneration.

Andreoli MT, Pinnolis M, Kieser T, Sun J, Andreoli CM.

Digit J Ophthalmol. 2015 Sep 11;21(3):1-17. doi: 10.5693/djo.01.2015.04.002. eCollection 2015.

14.

Characterization of circulating and endothelial progenitor cells in patients with extreme-duration type 1 diabetes.

Hernandez SL, Gong JH, Chen L, Wu IH, Sun JK, Keenan HA, King GL.

Diabetes Care. 2014 Aug;37(8):2193-201. doi: 10.2337/dc13-2547. Epub 2014 Apr 29.

15.

Influence of diabetes and diabetes type on anatomic and visual outcomes following central rein vein occlusion.

Santiago JG, Walia S, Sun JK, Cavallerano JD, Haddad ZA, Aiello LP, Silva PS.

Eye (Lond). 2014 Mar;28(3):259-68. doi: 10.1038/eye.2014.1. Epub 2014 Feb 14.

16.

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators.

N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.

17.

Sexual dysfunction as a marker of cardiovascular disease in males with 50 or more years of type 1 diabetes.

Turek SJ, Hastings SM, Sun JK, King GL, Keenan HA.

Diabetes Care. 2013 Oct;36(10):3222-6. doi: 10.2337/dc13-0294. Epub 2013 Jun 18.

18.

Antiangiogenic therapy for ischemic retinopathies.

Al-Latayfeh M, Silva PS, Sun JK, Aiello LP.

Cold Spring Harb Perspect Med. 2012 Jun;2(6):a006411. doi: 10.1101/cshperspect.a006411.

19.

Evaluation of visual acuity measurements after autorefraction vs manual refraction in eyes with and without diabetic macular edema.

Sun JK, Qin H, Aiello LP, Melia M, Beck RW, Andreoli CM, Edwards PA, Glassman AR, Pavlica MR; Diabetic Retinopathy Clinical Research Network.

Arch Ophthalmol. 2012 Apr;130(4):470-9. doi: 10.1001/archophthalmol.2011.377. Epub 2011 Dec 12.

20.

Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study.

Sun JK, Keenan HA, Cavallerano JD, Asztalos BF, Schaefer EJ, Sell DR, Strauch CM, Monnier VM, Doria A, Aiello LP, King GL.

Diabetes Care. 2011 Apr;34(4):968-74. doi: 10.2337/dc10-1675.

Supplemental Content

Loading ...
Support Center